National registry for esophageal atresia cases

National Register of Oesophageal Atresia

This study is setting up a national registry in France to gather information about esophageal atresia in newborns to better understand the condition and improve care for affected infants.

Quick facts

• Study type: Observational
• Enrollment: 2500 (estimated)
• Ages: N/A to 1 Year
• Sex: All
• Sponsor: University Hospital, Lille (Academic / other)
• Locations: 37 sites (Saint Denis, La Réunion and 36 other locations)
• Trial ID: NCT02883725 on ClinicalTrials.gov

What this trial studies

This observational study aims to establish a national registry in France to collect data on the prevalence and characteristics of esophageal atresia among newborns. It will document the circumstances of diagnosis and track the short-term outcomes of affected infants during their first year of life. The registry will help in understanding the condition better and may inform future clinical practices and interventions. Data collection will focus on various phenotypic traits and associated malformations.

Who should consider this trial

Good fit: Ideal candidates for this study are infants born in France diagnosed with esophageal atresia.

Not a fit: Patients born outside of France will not benefit from this study.

Why it matters

Potential benefit: If successful, this registry could improve understanding and management of esophageal atresia, leading to better outcomes for affected infants.

How similar studies have performed: While this approach of establishing a registry is common, the specific focus on esophageal atresia in France may provide novel insights into this condition.

Eligibility criteria

Inclusion Criteria:

* To be born in France
* To have a esophageal atresia

Exclusion Criteria:

* To be born abroad

Where this trial is running

Saint Denis, La Réunion and 36 other locations

• CHU Félix-Guyon — Saint Denis, La Réunion, France (Recruiting)
• CHU Amiens-Picardie — Amiens, France (Recruiting)
• CHU d'Angers — Angers, France (Recruiting)
• CHRU Besançon — Besançon, France (Recruiting)
• CHU de Bordeaux — Bordeaux, France (Recruiting)
• CHRU Brest — Brest, France (Recruiting)
• HFME de Lyon — Bron, France (Recruiting)
• CHU de Caen — Caen, France (Recruiting)
• CHU de Clermont-Ferrand — Clermont-Ferrand, France (Recruiting)
• Hôpitaux Civils de Colmar — Colmar, France (Recruiting)
• CHI Créteil — Créteil, France (Recruiting)
• CHU Dijon Bourgogne — Dijon, France (Recruiting)
• CHU de Grenoble — La Tronche, France (Recruiting)
• AP-HP CHU Kremlin-Bicêtre — Le Kremlin-Bicêtre, France (Recruiting)
• CH Le Mans — Le Mans, France (Recruiting)
• CHRU,Hôpital Jeanne de Flandres — Lille, France (Recruiting)
• CHU de Limoges — Limoges, France (Recruiting)
• AP-HM La Timone — Marseille, France (Recruiting)
• AP-HM Nord — Marseille, France (Recruiting)
• CHRU de Montpellier — Montpellier, France (Recruiting)
• CHU de Nantes — Nantes, France (Recruiting)
• CHU de Nice — Nice, France (Recruiting)
• CHR d'Orléans — Orléans, France (Recruiting)
• AP-HP Armand Trousseau — Paris, France (Recruiting)
• AP-HP Necker-Enfants malades — Paris, France (Recruiting)
• AP-HP Robert-Debré — Paris, France (Recruiting)
• CHU de Poitiers — Poitiers, France (Recruiting)
• CHU de Reims — Reims, France (Recruiting)
• CHU de Rennes — Rennes, France (Recruiting)
• CHU de Rouen — Rouen, France (Recruiting)
• CHU de Saint-Etienne — Saint-Priest en Jarez, France (Recruiting)
• CHU de Strasbourg — Strasbourg, France (Recruiting)
• CHU de Toulouse — Toulouse, France (Recruiting)
• CHRU de Tours — Tours, France (Recruiting)
• CHU de Nancy — Vandœuvre-lès-Nancy, France (Recruiting)
• CHU de Pointe-à-Pitre — Pointe-à-Pitre, Guadeloupe (Recruiting)
• CHU de Martinique — Fort-de-France, Martinique (Recruiting)

Study contacts

• Principal investigator: Frédéric Gottrand, MD, PhD — University Hospital, Lille
• Study coordinator: Frédéric Gottrand, MD,PhD

Conditions Esophageal Atresia; Esophageal atresia